Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Electrocardiography × 1 year × Clear all

Status

Completed 12 Active not recruiting 4 Terminated 3 Recruiting 2 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Melanoma 1 Cardiotoxicity 1

Interventions

Interviews as Topic 6 Educational Status 6 Standard of Care 4 Specimen Handling 4 Surveys and Questionnaires 3 Observation 3 Methods 3 Fluorouracil 3 Fluorodeoxyglucose F18 3 Early Intervention, Educational 3 Dexamethasone 3 Chemoradiotherapy 3 Blood Specimen Collection 3 Biopsy 3 130-nm albumin-bound paclitaxel 3 lenvatinib 2 durvalumab 2 camrelizumab 2 Transcutaneous Electric Nerve Stimulation 2 Temozolomide 2 Surgical Procedures, Operative 2 Radiotherapy 2 Practice Guidelines as Topic 2 Patient Navigation 2 Oxaliplatin 2 Nivolumab 2 Leucovorin 2 Letrozole 2 Health Promotion 2 Genetic Testing 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06605833 2025-10-01

CARD-IO

Royal Marsden NHS Foundation Trust

Enrolling by invitation

Melanoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡